One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes did not meet its primary endpoint, but a preplanned subgroup analysis found a statistically significant effect of treatment ...
Apr 8, 2024
0
18
There is a pressing need to explore and understand which social determinants of health (SDOH) and health inequities act as significant, influential factors that contribute to low breast cancer screening behaviors in the United ...
Mar 4, 2024
0
0
For patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) improves progression-free survival (PFS), ...
Jan 29, 2024
0
0
Patients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new treatment option. The Alliance for Clinical Trials in Oncology has announced positive results from the Phase III AMBASSADOR ...
Jan 26, 2024
0
0
Probiotics, specifically lactobacillus, demonstrated significant ability to delay a COVID infection and reduce symptoms among a group of unvaccinated people who had been in contact with someone in their household diagnosed ...
Dec 19, 2023
0
5
The authors of a new study are warning people with type 1 diabetes to use fitness video games with caution.
Dec 1, 2023
0
18
As part of its ongoing quest to advance better brain health and performance, new research led by Center for BrainHealth at The University of Texas at Dallas investigated neural biomarkers associated with improvements on a ...
Nov 30, 2023
0
0
A survey from Ann & Robert H. Lurie Children's Hospital of Chicago found that 40% of parents who worked remotely during the pandemic reported higher parenting stress compared with only 27% of parents who worked onsite.
Nov 3, 2023
0
1
Researchers have developed a machine learning model that shows promising results in predicting the risk of critical bleeding in patients with immune thrombocytopenia (ITP).
Sep 28, 2023
0
13
Early initiation of the sodium glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in hospitalized patients ...
Aug 29, 2023
0
1
